These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Significance of molecular biomarkers in idiopathic pulmonary fibrosis: A mini review. Chiba H; Otsuka M; Takahashi H Respir Investig; 2018 Sep; 56(5):384-391. PubMed ID: 30030108 [TBL] [Abstract][Full Text] [Related]
29. Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Rottoli P; Magi B; Cianti R; Bargagli E; Vagaggini C; Nikiforakis N; Pallini V; Bini L Proteomics; 2005 Jul; 5(10):2612-8. PubMed ID: 15924291 [TBL] [Abstract][Full Text] [Related]
30. The disturbed redox-balance in pulmonary fibrosis is modulated by the plant flavonoid quercetin. Veith C; Drent M; Bast A; van Schooten FJ; Boots AW Toxicol Appl Pharmacol; 2017 Dec; 336():40-48. PubMed ID: 28987380 [TBL] [Abstract][Full Text] [Related]
31. Antioxidant supplementation and pulmonary function at rest and exercise. Deaton CM; Marlin DJ; Roberts CA; Smith N; Harris PA; Kelly FJ; Schroter RC Equine Vet J Suppl; 2002 Sep; (34):58-65. PubMed ID: 12405660 [TBL] [Abstract][Full Text] [Related]
32. The role of viral and bacterial infections in the pathogenesis of IPF: a systematic review and meta-analysis. Mostafaei S; Sayad B; Azar MEF; Doroudian M; Hadifar S; Behrouzi A; Riahi P; Hussen BM; Bayat B; Nahand JS; Moghoofei M Respir Res; 2021 Feb; 22(1):53. PubMed ID: 33579274 [TBL] [Abstract][Full Text] [Related]
33. Bronchoalveolar glutathione and nitrite/nitrate in idiopathic pulmonary fibrosis and sarcoidosis. Montaldo C; Cannas E; Ledda M; Rosetti L; Congiu L; Atzori L Sarcoidosis Vasc Diffuse Lung Dis; 2002 Mar; 19(1):54-8. PubMed ID: 12002386 [TBL] [Abstract][Full Text] [Related]
34. Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition. Milara J; Navarro R; Juan G; Peiró T; Serrano A; Ramón M; Morcillo E; Cortijo J Thorax; 2012 Feb; 67(2):147-56. PubMed ID: 22106015 [TBL] [Abstract][Full Text] [Related]
35. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis. Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180 [TBL] [Abstract][Full Text] [Related]
36. The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Meyer A; Buhl R; Magnussen H Eur Respir J; 1994 Mar; 7(3):431-6. PubMed ID: 8013597 [TBL] [Abstract][Full Text] [Related]
37. Identification of MMP28 as a biomarker for the differential diagnosis of idiopathic pulmonary fibrosis. Maldonado M; Buendía-Roldán I; Vicens-Zygmunt V; Planas L; Molina-Molina M; Selman M; Pardo A PLoS One; 2018; 13(9):e0203779. PubMed ID: 30208119 [TBL] [Abstract][Full Text] [Related]
38. Bronchoalveolar lavage in idiopathic pulmonary fibrosis: what does it tell us? Pesci A; Ricchiuti E; Ruggiero R; De Micheli A Respir Med; 2010 Jul; 104 Suppl 1():S70-3. PubMed ID: 20471812 [TBL] [Abstract][Full Text] [Related]
39. Exercise decreases plasma antioxidant capacity and increases urinary isoprostanes of IPF patients. Jackson R; Ramos C; Gupta C; Gomez-Marin O Respir Med; 2010 Dec; 104(12):1919-28. PubMed ID: 20739168 [TBL] [Abstract][Full Text] [Related]